Skip to main content

Therapeutic approaches to the control of coronary atherosclerosis

  • Conference paper
  • 1223 Accesses

Summary

Atherosclerosis is a multifactorial disease which culminates in the ruptured plaque seen at autopsy. Hypercholesterolaemia, subintimal accumulation of lipid, monocyte adhesion followed by penetration across the endothelium, the conversion of monocytes to macrophages and smooth muscle cell proliferation and migration are some of the events involved in the early stages of lesion formation. Late events include the formation of excess ground substance and collagen, and the formation of the fibrotic cap. Young lesions tend to be more fragile than “old” calcified lesions, and it is these young lesions which rupture, haemorrhage and provide anchor points for platelets.

Therapeutic interventions aimed at controlling lesion formation include those which reduce risk factors, including hypertension as well as those which interfere with the cascade of events involved in lesion formation. Agents which lower plasma cholesterol provide one approach. Another approach is to use calcium antagonists which not only lower blood pressure, but also directly interfere with some of the metabolic events involved in lesion formation.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Daly MJ, Elz JS, Nayler WG (1987) Contracture and the calcium paradox in the rat heart. Circ Res 61: 560–569

    PubMed  CAS  Google Scholar 

  2. Fleckenstein A, Frey M, Thimm F, Fleckenstein-Grun G (1990) Excessive mural calcium overload a predominant causal factor in the development of stenosing coronary plaques in humans. Cardiovasc Drugs Ther 4: 1005–1014

    Article  PubMed  Google Scholar 

  3. Fuster V, Stein B, Ambrose JA, Badimon I, Badimon JJ, Chesbro JH (1990) Atherosclerotic plaque rupture and thrombis: evolving concepts. Circulation 82 (Suppl II): 11–47–11–59

    Google Scholar 

  4. Gottlieb SO, Brinker JA, Mellitis ED, Aschuff SC, Baughman KL. Traill TA, Weiss JL, Reitz BA, Weisfeldt M, Gerstenblith G (1989) Effect of nifedipine on the development of coronary bypass graft stenosis in high-risk patients: a randomized double-blind, placebo- controlled trial. Circulation 80 (Suppl 2) 11–228 (abstract)

    Google Scholar 

  5. Henry PD, Bentley KI (1981) Suppression of atherogenesis in cholesterol-fed rabbits treated with nifedipine. J Clin Invest 68: 1366–1369

    Article  PubMed  CAS  Google Scholar 

  6. Kramsch DM, Aspen AJ, Rozier LJ (1981) Atherosclerosis: prevention by agents not affecting abnormal levels of blood lipids.Science 213: 1511–1512

    PubMed  CAS  Google Scholar 

  7. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW (1990) Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 335: 1109–1113

    Article  PubMed  CAS  Google Scholar 

  8. Loaldi A, Polese A, Montorsi P, De Cesare N, Fabbiocchi F, Ravagnani P, Guazzi M (1989) Comparison of nifedipine, propranolol and isosorbide dinitrate on angiographic progression and regression of coronary artery narrowing in angina pectoris. Am J Cardiol 64: 433–439

    Article  PubMed  CAS  Google Scholar 

  9. Nayler WG (1991) Molecular mechanisms involved in the anti-atherogenic effect of the calcium antagonists. In: Nayler WG, The Second Generation of Calcium Antagonists, Springer Verlag, Berlin, pp 139–151

    Google Scholar 

  10. Nayler WG, Pangiotopoulos S (1986) Calcium antagonism. In: Kelly DT(ed) Proceedings of II Asian Pacific Adalat Symposium, ADIS Press, New Zealand, pp 3–11

    Google Scholar 

  11. Neuser D, Rosen B (1990) Calcium antagonists and the proliferation of vascular smooth muscle cells. Satellite Symposium of 13th ISH meeting Montreal “Antiatherosclerotic Potential of Calcium Antagonists” pp 9–10

    Google Scholar 

  12. Nilsson I, Sjolund M, Palmberg L, Von Euler AM, Jonzon B, Thyborg I (1985) The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis 58: 109–112

    Article  PubMed  CAS  Google Scholar 

  13. Orekov AN, Tertov VU, Khashimov KA, Kudryashou SA, Smirnov VN (1986) Anti- atherosclerotic effects of verapamil in primary culture of human aortic intimal cells. J Hypertens 4 (Suppl 6): S 153–155

    Google Scholar 

  14. Ranganthan S, Jackson RL (1984) Effect of calcium channel blocking drugs on lysosomal function in human skin fibroblasts. Biochem Pharmacol 33: 2377–2382

    Article  Google Scholar 

  15. Ross R (1981) Atherosclerosis: a problem of the biology of arterial wall cells and their interactions with blood components. Arteriosclerosis 1: 293–311

    Article  PubMed  CAS  Google Scholar 

  16. Ross R (1986) The pathogenesis of atherosclerosis - an update. New England J Med 314: 488–500

    Article  CAS  Google Scholar 

  17. Ross R, Glomset JA (1976) The pathogenesis of atherosclerosis. New England J Med 295: 369–377

    Article  CAS  Google Scholar 

  18. Schwartz CJ, Kelley J, Nerem RM, Sprague EA (1989) Pathophysiology of the atherogenic process. Am J Cardiol 64: 236–305

    Article  Google Scholar 

  19. Stein O, Stein Y (1987) Effect of verapamil on cholesteryl ester hydrolysis and re-esteiifica- tion in macrophages. Atherosclerosis 7: 578–584

    CAS  Google Scholar 

  20. Stein O, Halpenis G, Stein Y (1987) Long term effects of verapamil on aortic smooth muscle cells cultured in the presence of hypercholesterolaemic serum. Atherosclerosis 7: 585–592

    CAS  Google Scholar 

  21. Tonks BD (1967) The estimation of cholesterol in serum: a classification and critical review of methods. Clin Biochem 1: 12–29

    Article  CAS  Google Scholar 

  22. Ware JA, Johnson PC, Smith M, Salzman EW (1986) Inhibition of human platelet aggrega-tion and cytoplasmic calcium response by calcium antagonists. Circ Res 59: 39–42

    PubMed  CAS  Google Scholar 

  23. Waters D, Lesperance J, Francetich M, Causey D, Theroux P, Chiang Y-K, Hudon G, Lemarbre L, Reitman M, Joyal M, Gosselin G, Dyrda I, Macer J, Havel RJ (1990) A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 82: 1940–1953

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

Nayler, W.G. (1994). Therapeutic approaches to the control of coronary atherosclerosis. In: Just, H., Hort, W., Zeiher, A.M. (eds) Arteriosclerosis. Steinkopff. https://doi.org/10.1007/978-3-642-85660-0_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85660-0_13

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85662-4

  • Online ISBN: 978-3-642-85660-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics